Voice For Health & Progress

Changes on the Horizon for Low-Income Subsidies: Prescription Co-Payments May Increase

A proposal in the President’s FY 2016 budget calls for an increase in Medicare Part D brand prescription co-payments for Part D beneficiaries who receive the Low-Income Subsidy (LIS).

Increasing brand drug co-pays will increase the cost burden for lower income Part D beneficiaries, while potentially compromising their access to needed care.

This proposal would:

• Make it harder for Part D beneficiaries to get necessary prescriptions

• Limit patient choices in prescriptions

• Force changes in prescribed treatment—even when the generic alternatives may not be the best option for a patient’s health needs

Medicare Part D is a successful program keeping costs lower for beneficiaries and for taxpayers while helping to improve quality of life for millions of seniors and individuals with disabilities. But for some low-income seniors and individuals with disabilities, accessing affordable prescriptions that meet their specific healthcare needs could soon become more difficult.

Read more here about Low-Income Subsidies.

« Back to Articles